Cover Image
Market Research Report
Product code
1022877

Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact - Global Forecast to 2026

Published: | MarketsandMarkets | 297 Pages | Delivery time: 1-2 business days

Price

Back to Top
Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact - Global Forecast to 2026
Published: August 9, 2021
MarketsandMarkets
Content info: 297 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.

Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.

The sterilization segment is expected to grow at the highest CAGR during the forecast period

Based on the products and services used in the control of HAIs, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.

The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control market

Based on end user, the hospital acquired infection control market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories). The hospitals & ICUs segment accounted for the largest share of the hospital acquired infection control market in 2020. Growth in this market is majorly attributed to the rising prevalence of HAIs, increasing adoption of single-use medical devices, and rising number of surgical procedures worldwide.

Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control market

The Asia Pacific hospital acquired infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the hospital acquired infection control market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the Hospital Acquired Infection Control market

The key players operating in the hospital acquired infection control market include STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany).

Research Coverage:

The report analyzes the hospital acquired infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as products and services, end user, and region. The report also includes a product portfolio matrix of various hospital acquired infection services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product & service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global hospital acquired infection control market. The report analyzes this market by products and services, and end user
  • Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global hospital acquired infection control market
  • Market Development: Comprehensive information on the lucrative emerging markets by products and services, and end user
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global hospital acquired infection control market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global hospital acquired infection control market.
Table of Contents
Product Code: MD 7956

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKET SEGMENTATION
    • FIGURE 1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • FIGURE 2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
    • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 8 TOP-DOWN APPROACH
    • FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET (2021-2026)
    • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 12 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 GEOGRAPHIC ANALYSIS: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET

4 PREMIUM INSIGHTS

  • 4.1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW
    • FIGURE 17 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER AND COUNTRY
    • FIGURE 18 HOSPITALS & ICUS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET IN 2020
  • 4.3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
  • 4.4 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION (2019-2026)
    • FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET DURING THE FORECAST PERIOD
  • 4.5 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: IMPACT ANALYSIS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 High incidence of hospital-acquired infections (HAIs)
      • 5.2.1.2 Increasing number of surgical procedures
    • TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED
      • 5.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases
      • 5.2.1.4 Technological advancements in sterilization equipment
      • 5.2.1.5 Growing awareness of environmental & personal hygiene due to COVID-19
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Concerns regarding the safety of reprocessed instruments
      • 5.2.2.2 Adverse effects of chemical disinfectants
      • 5.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare settings
      • 5.2.3.2 Rising adoption of single-use medical nonwovens and devices
      • 5.2.3.3 Growing healthcare industry and outsourcing of operations to emerging countries
    • FIGURE 22 INDIA: HEALTHCARE SECTOR GROWTH TREND (USD BILLION)
    • FIGURE 23 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Complications associated with hospital-acquired infection control procedures
      • 5.2.4.2 End-user noncompliance with sterilization standards
    • TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS
      • 5.2.4.3 Development of alternative technologies for surface disinfection

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 INCREASING ADOPTION OF STERILIZATION USING NO2
    • 6.2.2 ROBOTICS UTILIZATION FOR DISINFECTION
    • 6.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS
    • 6.2.4 LAYERING/BUNDLING IN INFECTION PREVENTION
  • 6.3 REGULATORY ANALYSIS
    • 6.3.1 REGULATORY JURISDICTION
    • TABLE 6 FDA- AND EPA-REGISTERED PRODUCT CATEGORIES
    • 6.3.2 BY REGION
      • 6.3.2.1 North America
        • 6.3.2.1.1 US
    • FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
        • 6.3.2.1.2 Canada
    • TABLE 7 SPAULDING'S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING
      • 6.3.2.2 Europe
    • TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION
    • FIGURE 25 CE MARKING FOR REPROCESSED MEDICAL DEVICES
      • 6.3.2.3 Asia Pacific
        • 6.3.2.3.1 Japan
    • TABLE 9 SOME GUIDELINES FOLLOWED UNDER ISO IN JAPAN
    • TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES
        • 6.3.2.3.2 Australia
      • 6.3.2.4 Latin America
    • 6.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19
      • 6.3.3.1 Sterilizers
    • TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS
      • 6.3.3.2 Disinfectant devices
    • TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES
  • 6.4 TECHNOLOGY ANALYSIS
    • 6.4.1 KEY TECHNOLOGIES
    • 6.4.2 COMPLEMENTARY TECHNOLOGIES
    • 6.4.3 ADJACENT TECHNOLOGIES
  • 6.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 13 PORTER'S FIVE FORCES ANALYSIS (2020): HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
    • 6.5.1 THREAT FROM NEW ENTRANTS
    • 6.5.2 THREAT FROM SUBSTITUTES
    • 6.5.3 BARGAINING POWER OF SUPPLIERS
    • 6.5.4 BARGAINING POWER OF BUYERS
    • 6.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.6 ECOSYSTEM ANALYSIS
    • FIGURE 26 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS
  • 6.7 VALUE CHAIN ANALYSIS
    • FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS
  • 6.8 TRADE DATA
    • 6.8.1 EXPORT DATA (USD)
    • 6.8.2 IMPORT DATA (USD)
  • 6.9 PATENT ANALYSIS
    • 6.9.1 PATENT PUBLICATION TRENDS FOR HOSPITAL-ACQUIRED INFECTION CONTROL
    • FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011-JULY 2021)
    • 6.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011-JULY 2021)
    • FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011-JULY 2021)
    • TABLE 14 LIST OF FEW PATENTS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, 2020-2021
  • 6.10 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET

7 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS
    • TABLE 16 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 7.2 PROTECTIVE BARRIERS
    • 7.2.1 RISING ADOPTION OF NONWOVENS IN SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH
    • TABLE 17 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 STERILIZATION
    • TABLE 18 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 19 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.1 STERILIZATION EQUIPMENT
      • 7.3.1.1 Effectiveness of sterilization equipment in sterilizing heat-sensitive products is expected to boost the market growth
    • TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.2 STERILIZATION SERVICES
      • 7.3.2.1 Increasing prevalence of HAIs and rising surgical interventions to drive market growth
    • TABLE 21 STERILIZATION SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.3 STERILIZATION CONSUMABLES & ACCESSORIES
      • 7.3.3.1 Low cost and efficacy of sterilization consumables & accessories in monitoring the sterilization process to drive market growth
    • TABLE 22 STERILIZATION CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 DISINFECTANTS
    • TABLE 23 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION
    • TABLE 24 COMMON DISINFECTANTS USED IN HEALTHCARE SETTINGS
    • TABLE 25 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.1 DISINFECTANTS, BY TYPE
    • TABLE 26 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY TYPE, 2019-2026 (USD MILLION)
      • 7.4.1.1 Hand disinfectants
        • 7.4.1.1.1 Increasing availability of various hand disinfection options to aid market growth
    • TABLE 27 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
    • TABLE 28 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.4.1.2 Surface disinfectants
        • 7.4.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff
    • TABLE 29 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
    • TABLE 30 SURFACE DISINFECTANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.4.1.3 Skin disinfectants
        • 7.4.1.3.1 Growing awareness about different HAIs and SSIs to aid market growth
    • TABLE 31 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
    • TABLE 32 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.4.1.4 Instrument disinfectants
        • 7.4.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market
    • TABLE 33 SPAULDING'S CLASSIFICATION OF MEDICAL EQUIPMENT AND THE REQUIRED LEVEL OF REPROCESSING
    • TABLE 34 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.2 DISINFECTANTS, BY FORMULATION
    • TABLE 35 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION, 2019-2026 (USD MILLION)
      • 7.4.2.1 Liquid disinfectants
        • 7.4.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces
    • TABLE 36 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
    • TABLE 37 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.4.2.2 Disinfectant wipes
        • 7.4.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens
    • TABLE 38 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS
    • TABLE 39 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.4.2.3 Disinfectant sprays
        • 7.4.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters
    • TABLE 40 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS
    • TABLE 41 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 DISINFECTORS
    • 7.5.1 GROWING NEED TO REDUCE THE SPREAD OF HAIS IS DRIVING MARKET GROWTH
    • TABLE 42 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTORS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 ENDOSCOPE REPROCESSING PRODUCTS
    • 7.6.1 INCREASING NUMBER OF ENDOSCOPY PROCEDURES CONDUCTED TO DRIVE MARKET GROWTH
    • TABLE 43 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.7 OTHER INFECTION CONTROL PRODUCTS
    • TABLE 44 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER INFECTION CONTROL PRODUCTS, BY COUNTRY, 2019-2026 (USD MILLION)

8 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 45 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 IMPACT OF COVID-19 ON THE END USERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
  • 8.3 HOSPITALS & INTENSIVE CARE UNITS (ICUS)
    • 8.3.1 HIGH PREVALENCE OF HAIS TO DRIVE THE DEMAND FOR DISINFECTION AND STERILIZATION PRODUCTS AMONG HOSPITALS & INTENSIVE CARE UNITS
    • TABLE 46 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & INTENSIVE CARE UNITS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 AMBULATORY SURGERY & DIAGNOSTIC CENTERS
    • 8.4.1 GROWING NUMBER OF OUTPATIENTS AND AWARENESS OF MINIMALLY INVASIVE SURGERIES IS EXPECTED TO PROPEL MARKET GROWTH
    • TABLE 47 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGERY & DIAGNOSTIC CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 NURSING HOMES & MATERNITY CENTERS
    • 8.5.1 GROWING NEED TO ENSURE THE SAFETY OF ELDERLY PATIENTS AND RISING SURGICAL PROCEDURES IN WOMEN TO DRIVE THE ADOPTION OF HAI CONTROL PRODUCTS IN THIS END-USER SEGMENT
    • TABLE 48 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR NURSING HOMES & MATERNITY CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.6 OTHER END USERS
    • TABLE 49 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

9 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 31 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020)
    • TABLE 50 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
  • 9.3 NORTH AMERICA
    • TABLE 51 NATIONAL ACUTE CARE HOSPITAL HAI METRICS
    • FIGURE 32 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
    • TABLE 52 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 54 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 58 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 US
      • 9.3.1.1 Increasing prevalence of HAIs, high R&D expenditure, and the presence of well-established pharmaceutical, medical devices, and hospital industries to drive market growth
    • TABLE 59 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 60 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 US: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 63 US: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 64 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 CANADA
      • 9.3.2.1 High prevalence of HAIs to increase the adoption of infection control products in the country
    • TABLE 65 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 66 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 69 CANADA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 70 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 EUROPE
    • TABLE 71 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 73 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 EUROPE: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 77 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 GERMANY
      • 9.4.1.1 Rising incidence of nosocomial infections and chronic diseases to drive growth in the market in Germany
    • TABLE 78 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 79 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 GERMANY: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 GERMANY: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 83 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 FRANCE
      • 9.4.2.1 High healthcare spending in the country to favor market growth
    • TABLE 84 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 85 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 FRANCE: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 FRANCE: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 89 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 UK
      • 9.4.3.1 Rising number of surgical procedures to drive the market growth in the UK
    • TABLE 90 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 91 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 UK: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 UK: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 95 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 ITALY
      • 9.4.4.1 Improving quality and accessibility to medical care and technologies to support market growth
    • TABLE 96 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 97 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 ITALY: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 ITALY: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 101 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.5 SPAIN
      • 9.4.5.1 Rising incidence of chronic disorders to drive market growth
    • TABLE 102 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 103 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 SPAIN: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 106 SPAIN: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 107 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.6 REST OF EUROPE
    • TABLE 108 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 109 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 ROE: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 ROE: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 113 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 ASIA PACIFIC
    • FIGURE 33 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT
    • TABLE 114 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.1 JAPAN
      • 9.5.1.1 Rising standard of care due to the increasing healthcare expenditure to support market growth
    • TABLE 121 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 122 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 JAPAN: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 JAPAN: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 126 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.2 CHINA
      • 9.5.2.1 China is the fastest-growing market for hospital-acquired infection control products and services
    • FIGURE 34 CHINA: TOTAL NUMBER OF HOSPITAL BEDS (2009-2019)
    • TABLE 127 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 128 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 CHINA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 CHINA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 132 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.3 INDIA
      • 9.5.3.1 Large patient population to support the growth of the hospital-acquired infection control market in the country
    • TABLE 133 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 134 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 INDIA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 INDIA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 138 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.4 REST OF ASIA PACIFIC
    • FIGURE 35 NUMBER OF INBOUND VISITORS TO SOUTH KOREA FROM 2000 TO 2020 (IN MILLIONS)
    • TABLE 139 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 140 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 ROAPAC: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 ROAPAC: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 144 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.6 LATIN AMERICA
    • 9.6.1 RISING NUMBER OF COSMETIC SURGERIES IN THE REGION TO DRIVE THE ADOPTION OF INFECTION CONTROL PRODUCTS
    • TABLE 145 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 146 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 LATIN AMERICA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 LATIN AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 150 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.7 MIDDLE EAST & AFRICA
    • 9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
    • TABLE 151 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 152 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 155 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • TABLE 156 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
  • 10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 37 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2020
    • TABLE 157 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEGREE OF COMPETITION
  • 10.5 COMPETITIVE BENCHMARKING
    • 10.5.1 COMPANY PRODUCT/SERVICE FOOTPRINT
    • TABLE 158 COMPANY PRODUCT OFFERING FOOTPRINT (20 COMPANIES)
    • TABLE 159 COMPANY END-USER FOOTPRINT (20 COMPANIES)
    • TABLE 160 COMPANY REGION FOOTPRINT (20 COMPANIES)
  • 10.6 COMPETITIVE LEADERSHIP MAPPING
    • 10.6.1 STARS
    • 10.6.2 EMERGING LEADERS
    • 10.6.3 PERVASIVE PLAYERS
    • 10.6.4 PARTICIPANTS
    • FIGURE 38 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 161 PRODUCT LAUNCHES & APPROVALS, 2018-2021
    • 10.7.2 DEALS
    • TABLE 162 DEALS, 2018-2021
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 163 OTHER DEVELOPMENTS, 2018-2021

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 11.1.1 STERIS PLC
    • TABLE 164 STERIS PLC: BUSINESS OVERVIEW
    • FIGURE 39 STERIS PLC: COMPANY SNAPSHOT (2021)
    • 11.1.2 SOTERA HEALTH COMPANY
    • TABLE 165 SOTERA HEALTH COMPANY: BUSINESS OVERVIEW
    • FIGURE 40 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.3 GETINGE AB
    • TABLE 166 GETINGE AB: BUSINESS OVERVIEW
    • FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020)
    • 11.1.4 ADVANCED STERILIZATION PRODUCTS (ASP)
    • TABLE 167 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW
    • FIGURE 42 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.5 ECOLAB INC.
    • TABLE 168 ECOLAB INC.: BUSINESS OVERVIEW
    • FIGURE 43 ECOLAB INC.: COMPANY SNAPSHOT (2020)
    • 11.1.6 3M COMPANY
    • TABLE 169 3M COMPANY: BUSINESS OVERVIEW
    • FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.7 MATACHANA GROUP
    • TABLE 170 MATACHANA GROUP: BUSINESS OVERVIEW
    • 11.1.8 MMM GROUP
    • TABLE 171 MMM GROUP: BUSINESS OVERVIEW
    • 11.1.9 BELIMED AG (A SUBSIDIARY OF METALL ZUG GROUP)
    • TABLE 172 BELIMED AG: BUSINESS OVERVIEW
    • FIGURE 45 METALL ZUG GROUP: COMPANY SNAPSHOT (2020)
    • 11.1.10 RECKITT BENCKISER
    • TABLE 173 RECKITT BENCKISER: BUSINESS OVERVIEW
    • FIGURE 46 RECKITT BENCKISER: COMPANY SNAPSHOT (2020)
    • 11.1.11 METREX RESEARCH LLC (A SUBSIDIARY OF DANAHER CORPORATION)
    • TABLE 174 METREX RESEARCH: BUSINESS OVERVIEW
    • FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.12 MIELE GROUP
    • TABLE 175 MIELE GROUP: BUSINESS OVERVIEW
    • FIGURE 48 MIELE GROUP: COMPANY SNAPSHOT (2020)
    • 11.1.13 PAL INTERNATIONAL
    • TABLE 176 PAL INTERNATIONAL: BUSINESS OVERVIEW
    • 11.1.14 MELAG MEDIZINTECHNIK GMBH & CO. KG
    • TABLE 177 MELAG MEDIZINTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
    • 11.1.15 CONTEC, INC.
    • TABLE 178 CONTEC, INC.: BUSINESS OVERVIEW
    • 11.1.16 MEDALKAN
    • TABLE 179 MEDALKAN: BUSINESS OVERVIEW
    • 11.1.17 SYSTEC GMBH
    • TABLE 180 SYSTEC GMBH: BUSINESS OVERVIEW
    • 11.1.18 C.B.M. S.R.L. MEDICAL EQUIPMENT
    • TABLE 181 C.B.M. S.R.L. MEDICAL EQUIPMENT: BUSINESS OVERVIEW
    • 11.1.19 CONTINENTAL EQUIPMENT COMPANY
    • TABLE 182 CONTINENTAL EQUIPMENT COMPANY: BUSINESS OVERVIEW
    • 11.1.20 BETA-GAMMA-SERVICE GMBH & CO. KG
    • TABLE 183 BETA-GAMMA-SERVICE GMBH & CO. KG: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 MIDWEST STERILIZATION CORPORATION
    • 11.2.2 BLUE LINE STERILIZATION SERVICES LLC
    • 11.2.3 STERIPACK GROUP
    • 11.2.4 STERI-TEK
    • 11.2.5 STERILIZATION SERVICES

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS